Good Lifestyle

Like the deployment of the Covid vaccine had struck its stride across the United States, the leaders paused the use of theJohnson & Johnson Vaccine After blood clots emerged in a small handful of individuals. The pause came into effect on April 13 after six people experienced an adverse reaction on 6.8 million doses at the national level. In an interview of April 18 withMeet the press,Anthony Fauci, MD, Chief Medical Advisor White House, talked about theJohnson & Johnson vaccination break And specifically issued a warning on a certain medicine used to treat blood clots. Fauci said that doctors should pay attention because this common treatment of blood clots could do more harm than good in the case of Johnson & Johnson vaccine. Read on to learn more and for another update on this rare reaction, discoverThe only thing people who get blood clots after the vaccine have in common.

The six cases of reported blood clots were found in women aged 18 to 48 who received the Johnson & Johnson vaccine. Those who have very rare reaction noticed symptoms between six and 13 days after vaccination.

During an 18 April interview with NBCChuck Todd toMeet the press, Fauci warned that the heparin of drugs, a blood diluentused to prevent blood clots, could aggravate the situation. "The standard way you would think of treating clots is with anticoagulant heparin," said Fauci. "It would be contraindicated in this case because heparin could really make it worse."

And for more what could cause blood clots, know thatIf you take this medicine, you are more likely to get a blood clot.

"Do not treat patients With thrombotic events and thrombocytopenia following the reception of the J & J Covid-19 vaccine with heparin, unless raw tests are negative, "said centers for control and disease prevention. (CDC) reported in an emergency press release on 13 AV. According to Medscape, TestHeparin thrombocytopenia verifications, a coagulation condition that comes from treatment with the drug.

"If the test test is positive or unable to be carried out in the patient with thrombotic events and thrombocytopenia as a result of the reception of the J & J Covid-19 vaccine, non-heparinic anticoagulants and intravenous immunoglobulin to High dose must be strongly taken into account, "explains the CDC.

Other health officials have published similar warnings. "GivingHeparin actually acts aggravated, "Peter's brands, MD, Director of the Evaluation and Research Center on Organic Products with the Food & Drug Administration (FDA), stated during aAmerican Medical Association Webinar. "One of the people who have received heparin had clearly complications related to the reception of heparin."

And for more new Covid News updates sent directly,Sign up for our daily newsletter.

Fauci said the FDA and CDC made the decision to pause the use of the vaccine in order to obtain all the necessary information and to warn the physicians likely to see patients, especially women, who have this reaction. Unusual.

But he does not believe an extension on theJohnson & Johnson vaccination break will prolong the last Friday, when it expects the CDC and the FDA to make a decision. "We should have an answer as to where we are going with it. ... There will probably be a decision," said Fauci on ABCThis weekApril 18th. "I do not want to go ahead. But I do not think they will completely cancel."

And for knowing who is likely to experiment with another rare event with the vaccine, checkYou are more likely to get Covid after vaccination if you are on this age.

Although Fuci does not believe that the CDC and the FDA will advise a cancellation of Johnson & Johnson vaccine, he thinks some changes are as a result. Although it can not say with certainty, Fauci imagines that it will be a warning associated with the vaccine or that it will be restricted for use among some people, depending on age and perhaps sex.

"I think we'll come back with her and that could be restrictions. I do not know what it will be, if they will be age or sex or come back with a warning of some sort, stated inMeet the press. "I think there will probably be a kind of restriction or risk restriction or restriction. I do not think it will just go back and say," Ok, everything is fine, go on everything right now. "I think it will probably say," Okay, we will use it. But be careful in these circumstances. " And for knowing that could be the most subject to this question, discover If you have this type of blood, you are more likely to get blood clots .